Shire plc : Form 8 (DD) - Thomas Dittrich
May 02, 2018 06:02 ET
|
Shire Pharmaceuticals Group
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2 and 8.4 of the...
Shire plc : Form 8 (DD) - Flemming Ornskov
May 02, 2018 06:01 ET
|
Shire Pharmaceuticals Group
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2 and 8.4 of the...
Shire plc : Director/PDMR Shareholding
May 01, 2018 10:46 ET
|
Shire Pharmaceuticals Group
Director/PDMR Shareholding May 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities 1. Details of the...
Shire plc : Form 8 (DD) - Flemming Ornskov
May 01, 2018 07:01 ET
|
Shire Pharmaceuticals Group
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of...
Shire plc : Total voting rights
May 01, 2018 07:01 ET
|
Shire Pharmaceuticals Group
Total Voting Rights May 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and...
Shire plc : Rule 2.9 Announcement
May 01, 2018 02:01 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Rule 2.9 Announcement
April 27, 2018 02:01 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : 1st Quarter Results
April 26, 2018 07:01 ET
|
Shire Pharmaceuticals Group
Shire Delivers 7% Product Sales Growth and Robust Pipeline Progress in Q1 2018 Growth driven by Immunology, recently-launched products, and international expansion Innovative...
Shire plc : Rule 2.9 Announcement
April 26, 2018 02:02 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Shire plc : Shire announces revised proposal and extension of PUSU deadline to 8 May 2018
April 25, 2018 02:01 ET
|
Shire Pharmaceuticals Group
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR...